Latest News and Press Releases

Zutphen, The Netherlands, 31 August 2017  Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the Seventh Tranche of EUR 250,000 is issued as a private placement of 25...

Zutphen, The Netherlands, 11 August 2017  As of today, EUR 2,090,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 250,000 of warrants...

Zutphen, The Netherlands, 5 July 2017  Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a fourth Packed Tranche of EUR 250,000 is issued as a private placement of 25...

  Zutphen, The Netherlands, 15 June 2017  Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a third Packed Tranche of EUR 250,000 is issued as a private placement of 25...

Zutphen, The Netherlands, 1 June 2017  As of today, 100% of the EUR 1.0 million initial tranche issued on March 8, 2017 has been converted into shares by European Select Growth Opportunities Fund...

Zutphen, The Netherlands, 31 May 2017  As of today, EUR 940,000 out of the EUR 1.0 million tranche issued on March 8, 2017 have been converted into shares by European Select Growth Opportunities...

Zutphen, The Netherlands, 31 May 2017  As of today, EUR 940,000 out of the EUR 1.0 million tranche issued on March 8, 2017 have been converted into shares by European Select Growth Opportunities...

EBITDA improved compared to budget as a result of cost control Zutphen, the Netherlands - 31 May 2017 Market Update Q1 2017 The Q1 actual consolidated revenue of Esperite was higher compared to...

Zutphen, the Netherlands - 31 May 2017 The unfortunate liquidation procedure against Genoma SA, ruled on May 4th 2017, for which an appeal is still pending, has triggered the obligation to repay...

Zutphen, The Netherlands - 23 May 2017 Esperite N.V. (Euronext: ESP, "Esperite") announces that it has convened its Annual General Meeting of Shareholders ("AGM") to be held on 4 July 2017 at...